Order Article Reprints

Otero R, Solier-López A, Sánchez-López V, Oto J, Arellano E, Marín S, Jara-Palomares L, Elías T, Asencio MI, Blasco-Esquivias I, et al. Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study). Cancers. 2022; 14(11):2771. https://doi.org/10.3390/cancers14112771

Otero, Remedios, Aurora Solier-López, Verónica Sánchez-López, Julia Oto, Elena Arellano, Samira Marín, Luis Jara-Palomares, Teresa Elías, María Isabel Asencio, Isabel Blasco-Esquivias, and et al. 2022. "Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study)" Cancers 14, no. 11: 2771. https://doi.org/10.3390/cancers14112771

Otero, R., Solier-López, A., Sánchez-López, V., Oto, J., Arellano, E., Marín, S., Jara-Palomares, L., Elías, T., Asencio, M. I., Blasco-Esquivias, I., Rodríguez de la Borbolla, M., Sánchez-Díaz, J. M., Real-Domínguez, M., García-Cabrera, E., Rodríguez-Martorell, F. J., & Medina, P. (2022). Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study). Cancers, 14(11), 2771. https://doi.org/10.3390/cancers14112771